I'm just doing some research on CSS and there's a few things I'm curious about.
Why do they have borrowings of $456k when they have cash or cash equivalents of $4.4m?
Why does the YTD operating cashflow figure in the December quarter report differ to the figures in the 2013 half year report? Given they cover the same 6 months surely they should be identical. Same with the investing cashflow figures.
Why are they doing a deeply discounted and massive capital raising, ie 300m new shares, when they have net cash of $3.9m in a company whose restructuring has, in the December quarter, brought them to being nearly operating cashflow neutral?
Surely the cash on hand would suffice to grow the kingfish stocks to a greater level gradually without having to resort to such a capital raising until the overall performance and share price has improved.
The CR smacks of desperation in terms of pricing and number of shares.
- Forums
- ASX - By Stock
- some questions
CSS
clean seas seafood limited
Add to My Watchlist
0.00%
!
13.5¢

I'm just doing some research on CSS and there's a few things I'm...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.28M |
Open | High | Low | Value | Volume |
14.0¢ | 14.0¢ | 13.5¢ | $5.757K | 42.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 4475327 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 531104 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 4475327 | 0.135 |
2 | 12222 | 0.130 |
1 | 7200 | 0.125 |
1 | 7500 | 0.120 |
1 | 7826 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 531104 | 17 |
0.145 | 68473 | 1 |
0.150 | 2000 | 1 |
0.155 | 8000 | 1 |
0.200 | 7760 | 1 |
Last trade - 13.29pm 04/07/2025 (20 minute delay) ? |
Featured News
CSS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online